US Stock MarketDetailed Quotes

PODD Insulet

Watchlist
  • 280.560
  • -1.560-0.55%
Close Feb 14 16:00 ET
  • 280.560
  • 0.0000.00%
Post 17:04 ET
19.68BMarket Cap47.80P/E (TTM)

About Insulet Company

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Company Profile

SymbolPODD
Company NameInsulet
Listing DateMay 15, 2007
Issue Price15.00
Founded2000
CEOMr. James R. Hollingshead
MarketNASDAQ
Employees3000
Fiscal Year Ends12-31
Address100 Nagog Park
CityActon
ProvinceMassachusetts
CountryUnited States of America
Zip Code01720
Phone1-978-600-7000

Company Executives

  • Name
  • Position
  • Salary
  • James R. Hollingshead
  • Chief Executive Officer, President and Director
  • 12.38M
  • Lauren D. Budden
  • Group Vice President, Chief Accounting Officer and Controller
  • 1.44M
  • Ana Maria Chadwick
  • Executive Vice President, Chief Financial Officer and Treasurer
  • --
  • Mark N. Field
  • Senior Vice President and Chief Technology Officer
  • 2.37M
  • Eric Benjamin
  • Executive Vice President, Chief Product and Customer Experience Officer
  • 3.14M
  • Dan Manea
  • Senior Vice President and Chief Human Resources Officer
  • --
  • Prem Singh
  • Senior Vice President, Global Operations
  • --
  • John W. Kapples
  • Senior Vice President and General Counsel
  • 2.47M
  • Laetitia Cousin
  • Senior Vice President, Regulatory Affairs, Quality Assurance and Compliance
  • --
  • Timothy John Scannell
  • Chairman of the Board
  • 387.10K
  • Shacey Petrovic
  • Director
  • 278.46K
  • Flavia H. Pease
  • Director
  • --
  • Timothy C. Stonesifer
  • Director
  • --
  • Elizabeth H. Weatherman
  • Independent Director
  • 322.50K
  • Dr. Wayne A.I. Frederick, M.D.
  • Independent Director
  • 324.68K
  • Dr. Jessica Hopfield, PhD
  • Independent Director
  • 303.46K
  • Michael R. Minogue
  • Independent Director
  • 315.96K
  • Corinne H. Nevinny
  • Independent Director
  • 333.46K
  • Dr. Luciana Borio, M.D.
  • Independent Director
  • 308.46K

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More